Home - Products - GPCR/G Protein - Antibacterial - Levofloxacin Hydrochloride Impurity A

Levofloxacin Hydrochloride Impurity A

CAS No. 2254176-11-7

Levofloxacin Hydrochloride Impurity A( Levofloxacin Hydrochloride Impurity A(117707-40-1 Free base) )

Catalog No. M26150 CAS No. 2254176-11-7

Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 212 In Stock
5MG 187 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1135 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Levofloxacin Hydrochloride Impurity A
  • Note
    Research use only, not for human use.
  • Brief Description
    Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.
  • Description
    Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Levofloxacin Hydrochloride Impurity A(117707-40-1 Free base)
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2254176-11-7
  • Formula Weight
    397.83
  • Molecular Formula
    C18H21ClFN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C1=CN2[C@H](COC3=C(C(F)=CC(C1=O)=C23)N4CCN(CC4)C)C.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cristina Cruz-Hernandez, et al. Direct quantification of fatty acids in human milk by gas chromatography. J Chromatogr A. 2013 Apr 5;1284:174-9.
molnova catalog
related products
  • Norlichexanthone

    Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.

  • Ribocil

    Ribocil is a synthetic mimic of riboflavin 5’-monophosphate (FMN) that competes with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB.

  • Linaroside

    Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.